Search research articles
Contact Us
Filters
Showing results (381-390 of 436) with videos related to
Page
of 44
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor
H M Kantarjian, M Talpaz, D Kontoyiannis, et al.
Leukemia
|
June 1, 1996
Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first
P Anderlini, H M Ghaddar, T L Smith, et al.
Cancer
|
August 1, 1985
Remission from central nervous system involvement in adults with acute leukemia. Effect of intensive therapy and prognostic factors
D J Stewart, T L Smith, M J Keating, et al.
Cancer Treatment Reports
|
November 1, 1982
High-dose AMSA and autologous bone marrow transplantation in relapsed acute leukemia
A R Zander, L Vellekoop, K A Dicke, et al.
Leukemia
|
March 1, 1996
Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia
H M Kantarjian, M Beran, S O'Brien, et al.
Leukemia
|
July 1, 1988
Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome
M J Keating, T L Smith, H Kantarjian, et al.
British Journal of Haematology
|
March 1, 1991
Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes
E H Estey, R Kurzrock, M Talpaz, et al.
Bone Marrow Transplantation
|
January 1, 1989
Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemia
L J Horwitz, H M Kantarjian, S Jagannath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 1992
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma
J R Redman, F Cabanillas, W S Velasquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1984
Prediction of complete remission in patients with refractory acute leukemia treated with AMSA
E H Estey, M J Keating, T L Smith, et al.
Page
of 44
Search research articles
Search
Showing results (381-390 of 436) with videos related to
Sort By:
Page
of 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor
H M Kantarjian, M Talpaz, D Kontoyiannis, et al.
Leukemia
|
June 1, 1996
Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first
P Anderlini, H M Ghaddar, T L Smith, et al.
Cancer
|
August 1, 1985
Remission from central nervous system involvement in adults with acute leukemia. Effect of intensive therapy and prognostic factors
D J Stewart, T L Smith, M J Keating, et al.
Cancer Treatment Reports
|
November 1, 1982
High-dose AMSA and autologous bone marrow transplantation in relapsed acute leukemia
A R Zander, L Vellekoop, K A Dicke, et al.
Leukemia
|
March 1, 1996
Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia
H M Kantarjian, M Beran, S O'Brien, et al.
Leukemia
|
July 1, 1988
Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome
M J Keating, T L Smith, H Kantarjian, et al.
British Journal of Haematology
|
March 1, 1991
Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes
E H Estey, R Kurzrock, M Talpaz, et al.
Bone Marrow Transplantation
|
January 1, 1989
Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemia
L J Horwitz, H M Kantarjian, S Jagannath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 1992
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma
J R Redman, F Cabanillas, W S Velasquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1984
Prediction of complete remission in patients with refractory acute leukemia treated with AMSA
E H Estey, M J Keating, T L Smith, et al.
Page
of 44